Medical News

RSS

SRA International awarded MARCS Integration Contract

SRA International, Inc., a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced that, on behalf of the Food and Drug Administration (FDA), the Department of the Interior/National Business Center/Acquisition Services Directorate-Herndon has awarded SRA the Mission Accomplishment and Regulatory Compliance Services (MARCS) Integration Contract (MIC).

19 Jan 2010

CytoDyn commences enrollment in Cytolin clinical trial

Following approval of the Institutional Review Board, CytoDyn, Inc. has discharged its duty to register a clinical trial of Cytolin®, the Company’s lead product, with the government’s website at www.clinicaltrials.gov, ID NCT01048372. The public has online access to this federal database, which describes the key elements of clinical trials and their status.

19 Jan 2010

The price they paid

Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, writes about how a Virginia family got permission to get out-of-network treatment for one son's heart defect, and still ended up drowning in debt.

19 Jan 2010

Researchers propose a new model for breast cell differentiation

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding of the origins of breast cancer. The

19 Jan 2010

Repeated exposure to tobacco smoke makes lung cancer much worse

Repeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals.

19 Jan 2010

Health insurer stocks rise as Wall Street anticipates Republican victory in Mass.

"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).

19 Jan 2010

China Pediatric Pharmaceuticals applies for listing on NASDAQ

China Pediatric Pharmaceuticals, Inc., today announced it has applied for listing approval on the NASDAQ Capital Market (“NASDAQ”).

19 Jan 2010

A novel approach for funding children's genetic disease research

Parent Project Muscular Dystrophy together with Trisomy 18 Foundation are among 100 charities that earned a $25,000 grant during Round 1 of the Chase Community Giving Challenge on Facebook.

19 Jan 2010

US Oncology Foundation changes its name to Life Beyond Cancer Foundation

The US Oncology Foundation announced today that it is changing its name to the Life Beyond Cancer Foundation. This new name better captures the essence of hope that the organization aspires to provide to cancer patients and their families.

19 Jan 2010

Watson Laboratories files ANDA for Lidoderm

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lidocaine topical patch 8% prior to the expiration of U.S. Patent No. 5,827,529.

19 Jan 2010

Invatec's REEF HP PTA Balloon Catheter receives FDA marketing clearance

Invatec, a comprehensive innovator of cardiovascular products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its REEF HP™, a PTA Balloon Catheter, for use in peripheral high pressure dilatation procedures. The “lesion-specific” design of the balloon material is particularly useful in hard-to-dilate situations.

19 Jan 2010

Social factors still influence access to cancer services

People who develop the most common forms of cancer are still more likely to be diagnosed at a late stage in their disease if they live in a deprived area, new research has found.

19 Jan 2010

World Heart's Levacor VAD implant performed at INTEGRIS Baptist Medical Center

World Heart Corporation ("WorldHeart"), a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device ("VAD") was successfully performed at INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City on Wednesday, January 13, 2010.

19 Jan 2010

AccessDNA and Informed Medical Decisions team up to provide telephone-based genetic counseling services

AccessDNA, Inc., the leading online consumer resource for genetic-related information, services, and support, today announced it has partnered with Informed Medical Decisions, Inc., the only nationwide-network of independent genetic counselors, to provide telephone-based genetic counseling services to AccessDNA’s fast-growing base of online users.

19 Jan 2010

GOP effort to recruit House Democrats to oppose health overhaul stalls

"A week after House Minority Whip Eric Cantor (R-Va.) announced an effort to persuade dozens of Democrats to abandon their support for health care reform, he appears to have made little headway, and several of the targets that he has identified said they have yet to hear from him," Roll Call reports.

19 Jan 2010

California limits HMO wait times

The regulations by the California Department of Managed Health Care, in the works for much of the last decade, will require that patients be treated by HMO doctors within 10 business days of requesting an appointment, and by specialists within 15.

19 Jan 2010

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.

19 Jan 2010

Leafy green vegetables, folate and multivitamins can prevent lung cancer in smokers

Leafy green vegetables, folate, and some multivitamins could serve as protective factors against lung cancer in current and former smokers, according to a study that is a first step in understanding a complex association.

19 Jan 2010

WHO, CDC issue H1N1 updates

Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.

19 Jan 2010

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.

19 Jan 2010